Results 301 to 310 of about 98,614 (388)

Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F‐Positive Myeloproliferative Neoplasms

open access: yesCancer Medicine, Volume 14, Issue 13, July 2025.
ABSTRACT Background The incidence, outcomes and risk factors for AF in the JAK2V617F‐positive MPN patients are still unknown. Methods The clinical profiles of patients with JAK2V617F‐positive MPN were retrospectively analyzed. Multivariable Cox regression analysis was performed to identify risk factors of AF, thereby developing a risk prediction model.
Guangshuai Teng   +16 more
wiley   +1 more source

Acetaminophen Poisoning: Case Reports of Early Liver Dialysis for Hepatic Injury

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT In acetaminophen‐induced acute liver failure, early use of extracorporeal artificial liver support using BS330/HA330‐II filters improves liver function, coagulation profiles, bilirubin levels, and may obviate the need for liver transplantation.
Mitra Rahimi   +6 more
wiley   +1 more source

Clinical Relationship Between Serum ApoB, HER2, and Myocardial Ischemia Risk in Breast Cancer Patients

open access: yesCancer Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Background The risk factors and clinical prediction of cardiovascular comorbidities in patients with breast cancer have not been fully clarified. Aims This retrospective case–control study was designed to investigate the factors affecting myocardial ischemia occurrence in breast cancer patients.
Yeyan Lei   +5 more
wiley   +1 more source

Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer

open access: yesCancer Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Background Hepatocellular Carcinoma (HCC) ranks among the most prevalent human cancers and stands as the third most common cause of death related to cancer globally. Current therapies for HCC include surgical resection, local ablation, chemoembolization, liver transplantation, and molecular‐targeted therapy. Only a small number of patients are
Bin Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy